Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Yong Hoon | - |
dc.contributor.author | Her, Ae-Young | - |
dc.contributor.author | Jeong, Myung Ho | - |
dc.contributor.author | Kim, Byeong-Keuk | - |
dc.contributor.author | Hong, Sung-Jin | - |
dc.contributor.author | Park, Sang-Ho | - |
dc.contributor.author | Kim, Seunghwan | - |
dc.contributor.author | Ahn, Chul-Min | - |
dc.contributor.author | Kim, Jung-Sun | - |
dc.contributor.author | Ko, Young-Guk | - |
dc.contributor.author | Choi, Donghoon | - |
dc.contributor.author | Hong, Myeong-Ki | - |
dc.contributor.author | Jang, Yangsoo | - |
dc.date.accessioned | 2023-12-14T06:31:47Z | - |
dc.date.available | 2023-12-14T06:31:47Z | - |
dc.date.issued | 2023-08 | - |
dc.identifier.issn | 1897-5593 | - |
dc.identifier.issn | 1898-018X | - |
dc.identifier.uri | https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/25577 | - |
dc.description.abstract | Background: Because limited data are available, the present study investigated 2-year major clinical outcomes after angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin II type 1 receptor blockers (ARBs) therapy in patients with acute myocardial infarction (AMI) and prediabetes after successful implantation of newer-generation drug-eluting stents (DESs).Methods: Overall, 2932 patients with AMI and prediabetes were classified into two groups - the ACEIs group (n = 2059) and the ARBs group (n = 873). The primary endpoint was the occurrence of patient-orientedcomposite outcome (POCO), defined as all-cause death, recurrent myocardial infarction (Re-MI), or any repeat revascularization. The secondary endpoint was definite or probable stent thrombosis (ST).Results: The cumulative incidences of POCO (adjusted hazard ratio [aHR]: 1.020; 95% confidence interval [CI]: 0.740-1.404; p = 0.906), all-cause death (aHR: 1.394; 95% CI: 0.803-2.419; p = 0.238), Re-MI (aHR: 1.210; 95% CI: 0.626-2.340; p = 0.570), any repeat revascularization (aHR: 1.150; 95% CI: 0.713-1.855; p = 0.568), and ST (aHR: 1.736; 95% CI: 0.445-6.766; p = 0.427) were similar between the groups. These results were confirmed after propensity score-adjusted analysis.Conclusions: In this study, patients with AMI and prediabetes who received ACEIs or ARBs showed comparable clinical outcomes during the 2-year follow-up period. (Cardiol J 2023; 30, 4: 614-626) | - |
dc.format.extent | 13 | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | VIA MEDICA | - |
dc.title | Angiotensin converting enzyme inhibitors versus angiotensin II type 1 receptor blockers in patients with acute myocardial infarction and prediabetes after successful implantation of newer-generation drug-eluting stents | - |
dc.type | Article | - |
dc.publisher.location | 폴란드 | - |
dc.identifier.doi | 10.5603/CJ.a2021.0116 | - |
dc.identifier.scopusid | 2-s2.0-85170581547 | - |
dc.identifier.wosid | 001069329700001 | - |
dc.identifier.bibliographicCitation | CARDIOLOGY JOURNAL, v.30, no.4, pp 614 - 626 | - |
dc.citation.title | CARDIOLOGY JOURNAL | - |
dc.citation.volume | 30 | - |
dc.citation.number | 4 | - |
dc.citation.startPage | 614 | - |
dc.citation.endPage | 626 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Cardiovascular System & Cardiology | - |
dc.relation.journalWebOfScienceCategory | Cardiac & Cardiovascular Systems | - |
dc.subject.keywordPlus | ST-SEGMENT ELEVATION | - |
dc.subject.keywordPlus | ACUTE CORONARY SYNDROMES | - |
dc.subject.keywordPlus | DIABETES-MELLITUS | - |
dc.subject.keywordPlus | TASK-FORCE | - |
dc.subject.keywordPlus | GLYCATED HEMOGLOBIN | - |
dc.subject.keywordPlus | EUROPEAN-SOCIETY | - |
dc.subject.keywordPlus | ALL-CAUSE | - |
dc.subject.keywordPlus | CARDIOLOGY | - |
dc.subject.keywordPlus | MORTALITY | - |
dc.subject.keywordPlus | GLUCOSE | - |
dc.subject.keywordAuthor | angiotensin-converting enzyme inhibitor | - |
dc.subject.keywordAuthor | angiotensin receptor blocker | - |
dc.subject.keywordAuthor | myocardial infarction | - |
dc.subject.keywordAuthor | prediabetes | - |
dc.subject.keywordAuthor | outcomes | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(31538) 22, Soonchunhyang-ro, Asan-si, Chungcheongnam-do, Republic of Korea+82-41-530-1114
COPYRIGHT 2021 by SOONCHUNHYANG UNIVERSITY ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.